Docoh
Loading...

UNH Unitedhealth

UnitedHealth Group is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services.

Company profile

Ticker
UNH
Exchange
CEO
David Wichmann
Employees
Incorporated
Location
Fiscal year end
Former names
UNITED HEALTHCARE CORP
SEC CIK
Subsidiaries
1070715 B.C. Unlimited Liability Company • 1st Avenue Pharmacy, Inc. • 310 Canyon Medical, LLC • 4C MSO LLC • 5995 Minnetonka, LLC • ABCO International Holdings, LLC • AbleTo, Inc. • Access Administrators, Inc. • Access HealthSource Administrators, Inc. • Access HealthSource, Inc. ...
IRS number
411321939

UNH stock data

(
)

Calendar

3 Aug 21
28 Sep 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 19.83B 19.83B 19.83B 19.83B 19.83B 19.83B
Cash burn (monthly) 41M 207.92M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) 121.25M 614.87M n/a n/a n/a n/a
Cash remaining 19.71B 19.22B n/a n/a n/a n/a
Runway (months of cash) 480.8 92.4 n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
21 Sep 21 Witty Andrew Common Stock Grant Acquire A No No 0 155.903 0 70,936.696
21 Sep 21 John F Rex Common Stock Grant Acquire A No No 0 68.228 0 117,217.662
21 Sep 21 Thomas E Roos Common Stock Grant Acquire A No No 0 28.281 0 35,197.047
21 Sep 21 Brian R Thompson Common Stock Grant Acquire A No No 0 46.855 0 17,388.627
21 Sep 21 Marianne D Short Common Stock Grant Acquire A No No 0 41.969 0 149,956.152

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

85.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2452 2382 +2.9%
Opened positions 165 160 +3.1%
Closed positions 95 140 -32.1%
Increased positions 1106 1086 +1.8%
Reduced positions 874 846 +3.3%
13F shares
Current Prev Q Change
Total value 324.58B 301.95B +7.5%
Total shares 809.92M 810.93M -0.1%
Total puts 5.85M 4.95M +18.2%
Total calls 4.62M 4.86M -5.0%
Total put/call ratio 1.3 1.0 +24.4%
Largest owners
Shares Value Change
Vanguard 78.57M $31.46B -0.1%
BLK Blackrock 69.03M $27.64B -2.1%
FMR 50.45M $20.2B +0.6%
STT State Street 44.53M $17.83B +1.9%
TROW T. Rowe Price 35.05M $14.03B -6.3%
Capital World Investors 34.12M $13.66B +0.3%
Wellington Management 30.49M $12.21B -8.7%
Capital International Investors 18.42M $7.37B -2.6%
Capital Research Global Investors 18.14M $7.26B -4.8%
Geode Capital Management 15.11M $6.03B +4.7%
Largest transactions
Shares Bought/sold Change
Wellington Management 30.49M -2.92M -8.7%
TROW T. Rowe Price 35.05M -2.36M -6.3%
Amundi Pioneer Asset Management 0 -1.76M EXIT
Amundi 1.7M +1.7M NEW
BLK Blackrock 69.03M -1.46M -2.1%
Jennison Associates 1.95M +1.31M +205.8%
AMP Ameriprise Financial 3.11M -1.3M -29.4%
Viking Global Investors 1.8M -1.28M -41.6%
WDR Waddell & Reed Financial 0 -1.24M EXIT
MCQEF Macquarie 1.62M +1.23M +311.9%

Financial report summary

?
Competition
HumanaCVS HealthCigna HoldingCenteneAetnaAnthemPremierCignaSignify Health
Risks
  • We are subject to risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic, which could have a material adverse effect on our business, results of operations, financial condition and financial performance.
  • If we fail to estimate, price for and manage our medical costs in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows.
  • If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected.
  • If we sustain cyber-attacks or other privacy or data security incidents resulting in security breaches disrupting our operations or resulting in the unintended dissemination of protected personal information or proprietary or confidential information, we could suffer a loss of revenue and increased costs, exposure to significant liability, reputational harm and other serious negative consequences.
  • If we fail to develop and maintain satisfactory relationships with physicians, hospitals and other service providers, our business could be materially and adversely affected.
  • We are routinely subject to various legal actions due to the nature of our business, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows.
  • Any failure by us to manage successfully our strategic alliances or complete, manage or integrate acquisitions and other significant strategic transactions or relationships domestically or outside the United States could materially and adversely affect our business, prospects, results of operations, financial position and cash flows.
  • Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants.
  • Unfavorable economic conditions could materially and adversely affect our revenues and our results of operations.
  • Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance.
  • Our investment portfolio may suffer losses which could adversely affect our results of operations, financial position and cash flows.
  • If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected.
  • If we are not able to protect our proprietary rights to our databases, software and related products, our ability to market our knowledge and information-related businesses could be hindered and our results of operations, financial position and cash flows could be materially and adversely affected.
  • Any downgrades in our credit ratings could adversely affect our business, financial condition and results of operations.
  • Risks Related to the Regulation of Our Business
  • Our business activities are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.
  • As a result of our participation in various government health care programs, both as a payer and as a service provider to payers, we are exposed to additional risks associated with program funding, enrollments, payment adjustments, audits and government investigations which could materially and adversely affect our business, results of operations, financial position and cash flows.
  • Our businesses providing pharmacy care services face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses.
  • If we fail to comply with applicable privacy, security and data laws, regulations and standards, including with respect to third-party service providers utilizing protected personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.
  • Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our results of operations, financial position and cash flows.
Management Discussion
  • Decreased cash flows provided by operating activities were primarily driven by decreased net earnings due to the lower temporary deferral of care, the timing of prior year federal income tax payments and changes in working capital accounts. Other significant changes in sources or uses of cash year-over-year included increased net purchases of investments, purchases of redeemable noncontrolling interests and increased share repurchases, partially offset by increased customer funds administered.
  • As of June 30, 2021, our cash, cash equivalent, available-for-sale debt securities and equity securities balances of $64.7 billion included approximately $19.8 billion of cash and cash equivalents (of which $1.5 billion was available for general corporate use), $42.1 billion of debt securities and $2.8 billion of investments in equity securities. Given the significant portion of our portfolio held in cash and cash equivalents, we do not anticipate fluctuations in the aggregate fair value of our financial assets to have a material impact on our liquidity or capital position. Our available-for-sale debt securities portfolio had a weighted-average duration of 3.8 years and a weighted-average credit rating of “Double A” as of June 30, 2021. When multiple credit ratings are available for an individual security, the average of the available ratings is used to determine the weighted-average credit rating.
  • Cash Requirements. A summary of our cash requirements as of December 31, 2020 was disclosed in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2020 10-K. During the six months ended June 30, 2021, there were no material changes to this previously disclosed information outside the ordinary course of business. We believe our capital resources are sufficient to meet future, short-term and long-term, liquidity needs. We continually evaluate opportunities to expand our operations, including through internal development of new products, programs and technology applications and acquisitions.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: ago, dispensing, missed, noncontrolling, onset, redeemable, remaining, venture
Removed: accelerated, April, calendar, consisted, discount, drawn, extended, Interbank, LIBOR, London, mature, offered, privately, ranged, spread, Supplementary, term, transition, variable